GI Innovation

GI Innovation is a bio-venture company that develops innovative protein therapeutics through well-structured translational research. GI Innovation's main R&D areas are immuno-oncology agents and allergy therapeutics, utilizing the GI-SMART™ platform to develop dual-fusion proteins. The company is currently advancing its pipeline, which includes treatments for non-alcoholic steatohepatitis (NASH), as well as existing immuno-oncology agents and allergy therapeutics. GI Innovation is committed to developing treatments for patients with difficult-to-treat diseases around the world.